A new study adds to evidence that rosiglitazone — a drug used to treat type 2 diabetes — is associated with an increased risk of heart problems, especially heart failure.
A new study adds to evidence that rosiglitazone — a drug used to treat type 2 diabetes — is associated with an increased risk of heart problems, especially heart failure.